ELEVATEBIO
ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's most innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.
ELEVATEBIO
Industry:
Biotechnology
Founded:
2017-01-01
Status:
Active
Contact:
617-433-2600
Email Addresses:
[email protected]
Total Funding:
845 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Biofourmis
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics.
Catamaran Bio
Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-27 | Life Edit | Life Edit acquired by ElevateBio | N/A |
Investors List
EDBI
EDBI investment in Series C - ElevateBio
Emerson Collective
Emerson Collective investment in Series C - ElevateBio
Samsara BioCapital
Samsara BioCapital investment in Series C - ElevateBio
Surveyor Capital
Surveyor Capital investment in Series C - ElevateBio
ITOCHU Corporation
ITOCHU Corporation investment in Series C - ElevateBio
Redmile Group
Redmile Group investment in Series C - ElevateBio
Vertex Ventures
Vertex Ventures investment in Series C - ElevateBio
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - ElevateBio
Invus
Invus investment in Series C - ElevateBio
F2 Ventures
F2 Ventures investment in Series C - ElevateBio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | AlloVir | ElevateBio investment in Post-IPO Equity - AlloVir | 126.6 M USD |
| 2021-06-23 | Abata Therapeutics | ElevateBio investment in Series A - Abata Therapeutics | 95 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-02 | ElevateBio Announces Jill M. Mooney, Ph.D., Joins as Senior Vice President of Research and Development |
| 2020-03-05 | ElevateBio Appoints Kareem Reda as Chief Business Officer |